Skip to content
← Full study record

NCT01338987 · FLOW

Participant flow

Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation · Source last updated 2021-03-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Males undergoing first transplant who did not receive leuprolide.
    id
    FG000
    title
    Males That Did Not Receive Leuprolide for 1st Transplant
  2. description
    Males undergoing first transplant who were randomized to receive leuprolide.
    id
    FG001
    title
    Males Randomized to Receive Leuprolide for 1st Transplant
  3. description
    Females undergoing first transplant who all received leuprolide.
    id
    FG002
    title
    Females That Received Leuprolide for 1st Transplant
  4. description
    Individuals related to patients and who gave hematopoietic stem cells for patients receiving allogeneic bone marrow transplant on this study.
    id
    FG003
    title
    Matched Related Donors for Transplant
  5. description
    Patients receiving second allogeneic bone marrow transplant on this study.
    id
    FG004
    title
    Recipients of 2nd Transplant
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      type
      enrolled on new protocol
    2. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      type
      Disease progression on study
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        22
      4. group Id
        FG003
        num Subjects
        31
      5. group Id
        FG004
        num Subjects
        2
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        10
      2. group Id
        FG001
        num Subjects
        8
      3. group Id
        FG002
        num Subjects
        20
      4. group Id
        FG003
        num Subjects
        31
      5. group Id
        FG004
        num Subjects
        2
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        2
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Males undergoing first transplant who did not receive leuprolide.
    id
    FG000
    title
    Males That Did Not Receive Leuprolide for 1st Transplant
  2. description
    Males undergoing first transplant who were randomized to receive leuprolide.
    id
    FG001
    title
    Males Randomized to Receive Leuprolide for 1st Transplant
  3. description
    Females undergoing first transplant who all received leuprolide.
    id
    FG002
    title
    Females That Received Leuprolide for 1st Transplant
  4. description
    Individuals related to patients and who gave hematopoietic stem cells for patients receiving allogeneic bone marrow transplant on this study.
    id
    FG003
    title
    Matched Related Donors for Transplant
  5. description
    Patients receiving second allogeneic bone marrow transplant on this study.
    id
    FG004
    title
    Recipients of 2nd Transplant
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      type
      enrolled on new protocol
    2. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        1
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      type
      Disease progression on study
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        12
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        22
      4. group Id
        FG003
        num Subjects
        31
      5. group Id
        FG004
        num Subjects
        2
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        10
      2. group Id
        FG001
        num Subjects
        8
      3. group Id
        FG002
        num Subjects
        20
      4. group Id
        FG003
        num Subjects
        31
      5. group Id
        FG004
        num Subjects
        2
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        2
      4. group Id
        FG003
        num Subjects
        0
      5. group Id
        FG004
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice